Calamos Strategic Total Return Fund (NASDAQ:CSQ): Institutional Investors Are Worried

June 14, 2018 - By Ellis Scott

Sentiment for Calamos Strategic Total Return Fund (NASDAQ:CSQ)

Calamos Strategic Total Return Fund (NASDAQ:CSQ) institutional sentiment decreased to 1.39 in Q1 2018. Its down -1.16, from 2.55 in 2017Q4. The ratio turned negative, as 43 funds opened new or increased equity positions, while 31 cut down and sold holdings in Calamos Strategic Total Return Fund. The funds in our partner’s database now own: 17.89 million shares, down from 18.45 million shares in 2017Q4. Also, the number of funds holding Calamos Strategic Total Return Fund in their top 10 equity positions decreased from 1 to 0 for a decrease of 1. Sold All: 13 Reduced: 18 Increased: 28 New Position: 15.

Calamos Strategic Total Return Fund is a closed ended balanced mutual fund launched by Calamos Investments LLC. The company has market cap of $2.02 billion. The fund is managed by Calamos Advisors LLC. It has a 4.98 P/E ratio. It invests in the public equity and fixed income markets of the United States.

The stock increased 1.33% or $0.17 during the last trading session, reaching $13.06. About 270,394 shares traded. Calamos Strategic Total Return Fund (NASDAQ:CSQ) has risen 6.94% since June 14, 2017 and is uptrending. It has underperformed by 5.63% the S&P500.

Shaker Financial Services Llc holds 1.52% of its portfolio in Calamos Strategic Total Return Fund for 266,359 shares. Advisors Asset Management Inc. owns 2.02 million shares or 0.41% of their US portfolio. Moreover, Aviance Capital Partners Llc has 0.37% invested in the company for 104,392 shares. The Texas-based Oxbow Advisors Llc has invested 0.28% in the stock. Arete Wealth Advisors Llc, a Illinois-based fund reported 53,731 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: